OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer

Molecular Carcinogenesis

Volumn 51, Issue 2, 2012, Pages 165-173

  Gazouli, Maria ^a   Roubelakis, Maria G ^a   Theodoropoulos, George E ^a   Papailiou, Joanna ^a   Vaiopoulou, Anna ^a   Pappa, Kalliopi I ^a   Nikiteas, Nikolaos ^a   Anagnou, Nicholas P ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cancer stem cells; Colorectal cancer; OCT4; Sox 2; Stem cells

Indexed keywords

BIOLOGICAL MARKER; OCTAMER TRANSCRIPTION FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4 B1; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; CELL NUCLEUS; COLONOSCOPY; COLORECTAL CANCER; CYTOPLASM; ENZYME REACTIVATION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR BIOPSY; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; COLORECTAL NEOPLASMS; DNA PRIMERS; FEMALE; HUMANS; MALE; MIDDLE AGED; OCTAMER TRANSCRIPTION FACTOR-3; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICING;

EID: 84855211355     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20773     Document Type: Article

References (39)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-592.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-130.
3. Wang JC, Dick JE. Cancer stem cells: Lessons from leukemia. Trends Cell Biol 2005; 15: 494-501.
4. Dalerba P, Cho RW, Clarke MF. Cancer stem cells: Models and concepts. Annu Rev Med 2007; 58: 267-284.
5. Rosner MH, Vigano MA, Ozato K, et al. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 1990; 345: 686-692.
6. Nichols J, Zevnik B, Anastassiadis K, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor OCT4. Cell 1998; 95: 379-391.
7. Takeda J, Seino S, Bell GI. Human OCT3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res 1992; 20: 4613-4620.
8. Cauffman G, Liebaers I, Van Steirteghem A, Van de Velde H. POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells 2006; 24: 2685-2691.
9. Lee J, Kim HK, Rho JY, Han YM, Kim J. The human OCT-4 isoforms differ in their ability to confer self-renewal. J Biol Chem 2006; 281: 33554-33565.
10. Atlasi Y, Mowla SJ, Ziaee SA, Gokhale PJ, Andrews PW. OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells 2008; 26: 3068-3074.
11. Tai MH, Chang CC, Kiupel M, Webster JD, Olson LK, Trosko JE. OCT4 expression in adult human stem cells: Evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005; 26: 495-502.
12. Atlasi Y, Mowla SJ, Ziaee SA, Bahrami AR. OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer 2007; 120: 1598-1602.
13. Chen Z, Xu WR, Qian H, et al. OCT4, a novel marker for human gastric cancer. J Surg Oncol 2009; 99: 414-419.
14. Karoubi G, Gugger M, Schmid R, Dutly A. OCT4 expression in human non-small cell lung cancer: Implications for therapeutic intervention. Interact Cardiovasc Thorac Surg 2009; 8: 393-397.
15. Hochedlinger K, Yamada Y, Beard C, Jaenisch R. Ectopic expression of OCT-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 2005; 121: 465-477.
16. Ratajczak MZ, Machalinski B, Wojakowski W, Ratajczak J, Kucia M. A hypothesis for an embryonic origin of pluripotent OCT-4(+) stem cells in adult bone marrow and other tissues. Leukemia 2007; 21: 860-867.
17. Gidekel S, Pizov G, Bergman Y, Pikarsky E. OCT-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 2003; 4: 361-370.
18. Morson BC, Sobin LH. Histologic typing of intestinal tumours: WHO technical report. Geneva: WHO; 1976.
19. Sobin LH, Wittekind C. UICC TNM classification of malignant tumours, 5th edition. New York: Wiley-Liss; 1997.
20. Panagopoulos I, Moller E, Isaksson M, Martens F. A PCR/restriction digestion assay for the detection of the transcript variants 1 and 2 of POU5F1 Genes Chromosomes Cancer 2008; 47: 521-529.
21. Hansis C, Tang YX, Grifo JA, Krey LC. Analysis of Oct-4 expression and ploidy in individual human blastomeres. Mol Hum Reprod 2001; 7: 155-161.
22. Cheng L, Sung MT, Cassu-Rocca P, et al. OCT4: Biological functions and clinical application as a marker of germ cell neoplasia. J Pathol 2007; 211: 1-9.
23. Pesce M, Scholer HR. Oct-4: Gatekeeper in the beginning of mammalian development. Stem Cells 2001; 19: 271-278.
24. Ben-Porath I, Thomson MW, Carey VJ, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008; 40: 499-507.
25. Webster JD, Yuzbasiyan-Gurkan V, Trosko JE, Chang CC, Kiupel M. Expression of the embryonic transcription factor Oct4 in canine neoplasms: A potential marker for stem cell subpopulations in neoplasia. Vet Pathol 2007; 44: 893-900.
26. Katona TM, Billings SD, Montironi R, Lopez-Beltran A, Cheng L. Expression of OCT4 transcription factor in cutaneous neoplasia. Appl Immunohistochem Mol Morphol 2007; 1: 359-362.
27. Saigusa S, Tanaka K, Toiyama Y, et al. Correlation of CD133, OCT4 and SOX2 in rectal cancer and their association with distant recurrence after chemotherapy. Ann Surg Oncol 2009; 16: 3488-3498.
28. Lengner CJ, Camargo FD, Hochedlinger K, et al. OCT4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell 2007; 1: 403-415.
29. Liedtke S, Stephan M, Kögler G. Oct4 expression revisited: Potential pitfalls for data misinterpretation in stem cell research. Biol Chem 2008; 389: 845-850.
30. Cantz T, Key G, Bleidissel M, et al. Absence of OCT4 expression in somatic tumor cell lines. Stem Cells 2008; 26: 692-697.
31. Chang CC, Shieh GS, Wu P, Lin CC, Shiau AL, Wu CL. Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells. Cancer Res 2008; 68: 6281-6291.
32. Chiou SH, Yu CC, Huang CY, et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 2008; 14: 4085-4095.
33. Asadi MH, Mowla SJ, Fathi F, Aleyasin A, Asadzadeh J, Atlasi Y. OCT4B1, a novel spliced variant of OCT4, is higly expressed in gastric cancer and acts as an antiapoptotic factor. Int J Cancer 2010 (in press).
34. Wang Y, Meng L, Hu H, et al. Oct-4B isoform is differentially expressed in breast cancer cells: Hypermethylation of regulatory elements of Oct-4A suggests an alternative promoter and transcriptional start site for Oct-4B transcription. Biosci Rep 2010 [Epub ahead of print].
35. Suo G, Han J, Wang X, et al. Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun 2005; 337: 1047-1051.
36. Kotoula V, Papamichos SI, Lambropoulos AF. Revisiting OCT4 expression in peripheral blood mononuclear cells. Stem Cells 2008; 26: 290-291.
37. Looijenga LH, Stoop H, de Leeuw HP, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003; 63: 2244-2250.
38. de Jong J, Stoop H, Dohle G. et al. Diagnostc value of OCT3/4 for pre-invasive and invasive testicular germ cell tumors. J Pathol 2005; 206: 242-249.
39. Jones TD, Ulbright TM, Eble JN, et al. Oct4 staining in testicular tumors: A sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol 2004; 28: 935-940.